ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HLN Haleon

378.10
-0.70 (-0.18%)
03 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Haleon LSE:HLN London Ordinary Share GB00BMX86B70 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.70 -0.18% 378.10 376.90 377.10 380.00 376.00 377.40 7,147,785 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Offices-holdng Companies,nec 11.3B 1.05B 0.1148 32.84 34.6B
Haleon is listed in the Offices-holdng Companies sector of the London Stock Exchange with ticker HLN. The last closing price for Haleon was 378.80p. Over the last year, Haleon shares have traded in a share price range of 310.45p to 400.50p.

Haleon currently has 9,133,887,197 shares in issue. The market capitalisation of Haleon is £34.60 billion. Haleon has a price to earnings ratio (PE ratio) of 32.84.

Haleon Share Discussion Threads

Showing 301 to 324 of 550 messages
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
DateSubjectAuthorDiscuss
30/11/2022
18:56
Anyone have any insight into when GSK and PFE will have liquidated their holdings here?
rikky72
16/11/2022
11:47
PPE

Please stop posting this rubbish, or back it up with evidence! Trying to find some should keep you off this site for a while.

mercedes
16/11/2022
10:06
There isn't any, it's total puff!
ianood
16/11/2022
09:46
Evidence please on that statement.
grahamburn
16/11/2022
05:17
Pfizer are already dumping shares since the overhang was lifted in November after Haleon rejects requests for indemnifications on Zantac. Pfizer needing to build a cash position to fund the over 2,000 tort legal cases pending in the Florida state court in mid 2023..A further 51 state courts litigations are also in the pipeline with global litigation in other non US jurisdictions pending. GSK likely to follow suite with exiting its Haleon holdings to fund Zantac litigation costs.
paul planet earth
11/11/2022
10:09
These two stocks look like a good match to me :-)
richie1218
10/11/2022
16:39
My blood pressure is synchronised with the crashing share price !
abdullla
10/11/2022
16:12
I worry for your blood pressure, you seem to follow every rise and fall of the share price like you were personally hitching a ride on it.. :O
rikky72
10/11/2022
14:43
Crashing big time
abdullla
10/11/2022
12:20
I was reading that JNJ are also planning to float off their consumer health division.
spacecake
10/11/2022
09:36
Generally encouraging Q3 update today.



Happy to continue holding on these figures.

anhar
09/11/2022
12:26
Okay thanks
timothyo6
07/11/2022
13:48
FWIW...


27th oct Kepler hold tp 275p
14th oct Jefferies hold tp 280p
7th sept JP Morgan underweight tp 250p
16th aug RBC sect perform tp 300p
29th july Deutsche hold tp 300p
21st july Citigroup buy tp 360p
20th july BOA buy tp 385p
20th july Goldmans buy tp 350p
19th july UBS buy tp 380p
19th july Credit Suisse outperform tp 353p
19th july Barclays equal weight tp 347p

philanderer
14/10/2022
08:58
I have no idea of the future share price of HLN but it's odd how the price has been rising lately in view of your repeated bearish comments.

If you really are interested in what brokers and press etc. think, you need to check out all of them and see what the balance of their opinion is, not just cherry pick those that agree with your predetermined view. That's called confirmation bias and is one of the large range of classic small investor mistakes.

I personally have no interest in such views but make up my own mind, which is that on balance HLN is more worth keeping than selling now.

anhar
12/10/2022
03:55
'Wallet Investor’s Haleon long-term forecast indicated that the stock could be a non-viable investment. The algorithm-based forecasting service predicted that the share price could fall to £2.21 by the end of 2022 and decline throughout 2023 to trade at just £0.09 by the end of the year. The stock could effectively fall to zero by 2024, according to WalletInvestor’s forecast for the Haleon stock price in 5 years.

The Haleon stock 5-year forecast from Gov Capital similarly estimated that the American Depositary Receipts (ADRs) for Haleon listed in the US could drop to zero, but by November 2023.'

The most likely scenario is that due to the impact of generic drug labels, rising consumer inflation, and multi billion dollar Zantac litigation costs and settlements the share price will fall. The high burden of existing debt, rising interest rates, and flattening consumer sales reflected in the falling share price, note the price is down 16% since floatation with the expected off loading of both Pfizer and GSK's share holdings in November places more downward pressure on the share price on the foreseeable future.

paul planet earth
11/10/2022
13:40
Haleon sales targets impress Barclays

Bank has a 347p target on the Sensodyne, Panadol and Centrum owner

zho
08/10/2022
06:47
HALEON PLC
LON: HLN
OverviewNewsCompareFinancials
281.25 GBX -27.10 (-8.79%)past 1 month
7 Oct, 17:49 BST • Disclaimer

paul planet earth
07/10/2022
09:54
PPE

Please check the facts.......Its a bargain at these price levels

mercedes
07/10/2022
09:31
Strange how the share has been rising in recent weeks, given that the lock-in overhang from GSK and PFE is public knowledge and has been ever since the demerger details were released months ago.

I don't have the faintest idea of the manner in which they might dispose of their HLN shares and how it might affect the share price, but it just seems odd that if you are correct with your repetitive assertions about a price crash driven by big sales, why would the price be rising now?

Big cap share prices are driven by institutional trading, small private investors like us are irrelevant. So the rising price must be driven by inst buying on balance. Why would that be if it is feared that the price would soon collapse? Surely, if your view proves anywhere near accurate, they would be better waiting for the big HLN price crash you keep mentioning. In other words their opinions must be virtually the exact opposite of yours. I''m not saying that insts are always right, they're often wrong, but it does appear odd in this situation where there's only a few weeks at stake.

My view is that any potential big price fall is already in the price so there is little to fear. In any case, personally I hold shares very long term so I'm hanging on to my HLN allocation as it may prove to be a good share in years to come. Short term fears like you keep stating are of no concern to me and even if you're right, I'd see it as a buying opportunity and nothing to worry about. Nobody is going to care in several years time about a historical GSK/PFE overhang.

anhar
03/10/2022
11:20
Not long now till Pfizer and GSK both dump their 45% stakes in November after being told by Halitosis to get stuffed over Zantac indemnities..Just watch that share price dive in December..😅🤣😂28519;😊
paul planet earth
03/10/2022
09:57
My thought also, weak GBP, is this going to get gobbled up ?
spacecake
29/9/2022
16:55
Is some one stake building? One of the very few companies that is actually up.
netcurtains
27/9/2022
17:37
I repeat, a gift at this price.
mercedes
27/9/2022
11:36
HALEON PLC
LON: HLN
OverviewNewsCompareFinancials
281.70 GBX −4.65 (1.62%)today
27 Sept, 12:36 BST • Disclaimer

paul planet earth
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older

Your Recent History

Delayed Upgrade Clock